Primary Sjogren syndrome increases the risk of ...
Risk of osteonecrosis of the jaw in bisphosphonate and nonbisphosphonate groups among patients with and without primary Sjogren syndrome. Table Table2 2 illustrated the correlation between BP exposure and ONJ development among pSS and nonpSS patients. pSS patients using BPs had a significantly higher risk of ONJ (Adjusted HR:, 95% CI –) than .